Years ended December 31, | |||||||||
2017 | 2016 | 2015 | |||||||
$ | $ | $ | |||||||
Key management personnel compensation(1) | |||||||||
Salaries and short-term employee benefits | 2,081 | 2,430 | 2,957 | ||||||
Termination benefits | — | — | 843 | ||||||
Post-employment benefits | 59 | 78 | 119 | ||||||
Share-based compensation costs | 87 | 1,051 | 828 | ||||||
2,227 | 3,559 | 4,747 | |||||||
Other employees compensation: | |||||||||
Salaries and short-term employee benefits | 3,584 | 3,574 | 4,431 | ||||||
Termination benefits | 1,806 | — | 245 | ||||||
Post-employment benefits | 441 | 500 | 511 | ||||||
Share-based compensation costs | 95 | 31 | 91 | ||||||
5,926 | 4,105 | 5,278 | |||||||
Goods and services(2) | 13,575 | 21,217 | 21,429 | ||||||
Leasing costs, net of sublease receipts of $359 in 2017, $345 in 2016 and $380 in 2015(3) | 2,247 | 1,131 | 1,452 | ||||||
Refundable tax credits and grants | — | — | (23 | ) | |||||
Onerous contract expenses resulting from the Restructuring | — | — | (202 | ) | |||||
Transaction costs related to share purchase warrants | — | 56 | 2,208 | ||||||
Depreciation and amortization | 138 | 195 | 271 | ||||||
Impairment (reversal) losses | (44 | ) | 85 | 70 | |||||
Operating foreign exchange (gains) losses | (72 | ) | 39 | 199 | |||||
15,844 | 22,723 | 25,404 | |||||||
23,997 | 30,387 | 35,429 |
(1) | Key management includes the Company's directors and members of the executive management team. |
(2) | Goods and services include third-party R&D costs, laboratory supplies, professional fees, contracted sales force costs, marketing services, insurance and travel expenses. |
(3) | Leasing costs also include changes in the onerous lease provision (note 15 - provisions), other than attributable to the unwinding of the discount. |